+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Allergy Immunotherapy Market (2023-2028) Competitive Analysis, Impact of Covid-19, Ansoff Analysis

  • PDF Icon

    Report

  • 188 Pages
  • February 2024
  • Region: Global
  • Infogence Global Research
  • ID: 5910240
The Global Allergy Immunotherapy Market is estimated to be USD 1.86 Bn in 2023 and is expected to reach USD 2.75 Bn by 2028 growing at a CAGR of 8.13%.

Market dynamics, which refers to the ever-changing and evolving conditions, trends, and forces that impact the industries, is crucial for industry overview. It includes consumer demands, competition, technological advancements, economic shifts, and regulatory changes. We monitor the market and analyze the balance between demand and supply. Market dynamics that include drivers, restraints, opportunities, challenges, and insights are needed to make strategic decisions, whether entering new markets, launching new products, or setting pricing strategies.

The emerging trends in the market require market analysis to help set goals, make informed decisions about market entry and product development pricing, and inspire innovation to stay competitive and meet changing requirements. One of the most important elements is to analyze competitors to identify the gaps specific to the geographic location, product offerings, pricing, and opportunity areas for growth in internal and external development.

Understanding consumer behavior and market trends holistically is necessary to expand the company into new horizons and position itself in a new or existing market. It helps gain a competitive edge, save time & money, and reduce risks in the long term.

Market Segmentations

  • The Global Allergy Immunotherapy Market is segmented based on Type, Application and Distribution Channel, and Geography.
  • Subcutaneous immunotherapy involves the administration of allergens through subcutaneous injections. This traditional approach has been a longstanding method for managing allergies.
  • SCIT has effectively treated various allergic conditions, including respiratory and insect venom allergies. The long-term benefits of SCIT include reduced symptoms, decreased medication reliance, and prevention of disease progression-challenges related to patient compliance due to the need for frequent clinic visits for injections. Moreover, Ongoing research focuses on improving SCIT formulations, reducing treatment duration, and enhancing patient comfort.
  • Sublingual immunotherapy involves the administration of allergens in the form of sublingual tablets or drops. It offers a more convenient alternative to subcutaneous injections. SLIT is more suitable for patients, allowing self-administration at home after the initial dose under medical supervision. They are generally considered safer than SCIT, with a lower risk of systemic reactions. Ongoing research explores the expansion of SLIT indications to cover a broader spectrum of allergic conditions-the development of novel SLIT formulations, including fast-dissolving tablets and oral films.

Recent Development

  • HollisterStier Allergy introduced its latest product innovation, Ultrafiltered Dog, in the allergy market. The product is effective in the diagnosis and treatment of dog-sensitive patients. - Jan 2023
  • Allergy Partners, a single specialty allergy practice group, collaborated with Aimmune Therapeutics to offer Palforzia, an oral immunotherapy, directly to patients. - Oct 2022

Company Profiles

The report provides a detailed analysis of the competitors in the market. It covers the financial performance analysis for the publicly listed companies in the market. The report also offers detailed information on the companies' recent development and competitive scenario. Some of the companies covered in this report are ALK-Abelló A/S, Allergopharma (a subsidiary of Merck Group), Anergis SA, ASIT biotech, Biomay AG, etc.

Countries Studied

  • America (Argentina, Brazil, Canada, Chile, Colombia, Mexico, Peru, United States, Rest of Americas)
  • Europe (Austria, Belgium, Denmark, Finland, France, Germany, Italy, Ireland, Luxembourg, Netherlands, Norway, Poland, Russia, Spain, Sweden, Switzerland, United Kingdom, Rest of Europe)
  • Middle East and Africa (Egypt, Israel, Qatar, Nigeria, Saudi Arabia, South Africa, United Arab Emirates, Rest of MEA)
  • Asia-Pacific (Australia, Bangladesh, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri Lanka, Thailand, Taiwan, Rest of Asia-Pacific)

Competitive Quadrant

The report includes Competitive Quadrant, a proprietary tool to analyse and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Ansoff Analysis

  • The report presents a detailed Ansoff matrix analysis for the Global Allergy Immunotherapy Market. Ansoff Matrix, also known as Product/Market Expansion Grid, is a strategic tool used to design strategies for the growth of the company. The matrix can be used to evaluate approaches in four strategies viz. Market Development, Market Penetration, Product Development and Diversification. The matrix is also used for risk analysis to understand the risk involved with each approach.
  • The publisher analyses the Global Allergy Immunotherapy Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.
  • Based on the SWOT analysis conducted on the industry and industry players, the publisher has devised suitable strategies for market growth.

Why buy this report?

  • The report offers a comprehensive evaluation of the Global Allergy Immunotherapy Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
  • The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
  • The report includes an in-depth market analysis using Porter's 5 forces model, PESTLE Analysis, and the Ansoff Matrix. In addition, the impact of COVID-19 and the impact of economic slowdown & impending recession on the market are also featured in the report.
  • The report also includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
  • The report also contains the competitive analysis using Positioning Quadrants, the Proprietary competitive positioning tool.

Report Highlights

  • A complete analysis of the market, including parent industry
  • Important market dynamics and trends
  • Market segmentation
  • Historical, current, and projected size of the market based on value and volume
  • Market shares and strategies of key players
  • Recommendations to companies for strengthening their foothold in the market

Table of Contents

1 Report Description
1.1 Study Objectives
1.2 Market Definition
1.3 Currency
1.4 Years Considered
1.5 Language
1.6 Key Stakeholders
2 Research Methodology
2.1 Research Process
2.2 Data Collection and Validation
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Models
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.2 Top-Down Approach
2.4 Assumptions of the Study
2.5 Limitations of the Study
3 Executive Summary
3.1 Introduction
3.2 Market Size, Segmentations and Outlook
4 Market Dynamics
4.1 Drivers
4.1.1 Increasing Burden of Various Type of Allergies
4.1.2 Growing Focus on Research and Development Activities
4.1.3 High Demand for Advanced Procedures
4.2 Restraints
4.2.1 High Cost of Drugs
4.3 Opportunities
4.3.1 Increasing Adoption of Sublingual Immunotherapy Products
4.3.2 Increasing Use of Telemedicine and Digital Healthcare Solutions for Allergy Treatment
4.4 Challenges
4.4.1 Severe and Even Fatal Allergic Reactions
5 Market Analysis
5.1 Regulatory Scenario
5.2 Porter's Five Forces Analysis
5.3 PESTEL Analysis
5.4 SWOT Analysis
5.5 Impact of Covid-19
5.6 Ansoff Matrix Analysis
6 Global Allergy Immunotherapy Market, By Type
6.1 Introduction
6.2 Subcutaneous Immunotherapy
6.3 Sublingual Immunotherapy
7 Global Allergy Immunotherapy Market, By Application
7.1 Introduction
7.2 Allergic Rhinitis
7.3 Asthma
7.4 Atopic Dermatitis
7.5 Food Allergy
8 Global Allergy Immunotherapy Market, By Distribution Channel
8.1 Introduction
8.2 Institutional Sales
8.2.1 Government Hospitals
8.2.2 Private Hospitals
8.3 Retail Sales
8.3.1 Retail Pharmacy
8.3.2 Drug Stores
9 Americas' Allergy Immunotherapy Market
9.1 Introduction
9.2 Argentina
9.3 Brazil
9.4 Canada
9.5 Chile
9.6 Colombia
9.7 Mexico
9.8 Peru
9.9 United States
9.10 Rest of Americas
10 Europe's Allergy Immunotherapy Market
10.1 Introduction
10.2 Austria
10.3 Belgium
10.4 Denmark
10.5 Finland
10.6 France
10.7 Germany
10.8 Italy
10.9 Ireland
10.10 Luxembourg
10.11 Netherlands
10.12 Norway
10.13 Poland
10.14 Russia
10.15 Spain
10.16 Sweden
10.17 Switzerland
10.18 United Kingdom
10.19 Rest of Europe
11 Middle East and Africa's Allergy Immunotherapy Market
11.1 Introduction
11.2 Egypt
11.3 Israel
11.4 Nigeria
11.5 Qatar
11.6 Saudi Arabia
11.7 South Africa
11.8 United Arab Emirates
11.9 Rest of MEA
12 APAC's Allergy Immunotherapy Market
12.1 Introduction
12.2 Australia
12.3 Bangladesh
12.4 China
12.5 India
12.6 Indonesia
12.7 Japan
12.8 Malaysia
12.9 Philippines
12.10 Singapore
12.11 South Korea
12.12 Sri Lanka
12.13 Thailand
12.14 Taiwan
12.15 Rest of Asia-Pacific
13 Competitive Landscape
13.1 Competitive Quadrant
13.2 Market Share Analysis
13.3 Strategic Initiatives
13.3.1 M&A and Investments
13.3.2 Partnerships and Collaborations
13.3.3 Product Developments and Improvements
14 Company Profiles
14.1 Aimmune Therapeutics (acquired by Nestlé Health Science)
14.2 ALK-Abelló A/S
14.3 Allergopharma (a subsidiary of Merck Group)
14.4 Anergis SA
14.5 ASIT biotech
14.6 Biomay AG
14.7 Circassia Pharmaceuticals
14.8 CureVac AG
14.9 DBV Technologies
14.10 Genentech (a member of the Roche Group)
14.11 GlaxoSmithKline plc
14.12 HAL Allergy Group
14.13 Inmunotek
14.14 Leti Pharma GmbH
14.15 Merck & Co., Inc.
14.16 Novartis International AG
14.17 Sanofi
14.18 Stallergenes Greer
14.19 Torii Pharmaceutical Co. Ltd.
15 Appendix
15.1 Questionnaire

Companies Mentioned

  • Aimmune Therapeutics (acquired by Nestlé Health Science)
  • ALK-Abelló A/S
  • Allergopharma (a subsidiary of Merck Group)
  • Anergis SA
  • ASIT biotech
  • Biomay AG
  • Circassia Pharmaceuticals
  • CureVac AG
  • DBV Technologies
  • Genentech (a member of the Roche Group)
  • GlaxoSmithKline plc
  • HAL Allergy Group
  • Inmunotek
  • Leti Pharma GmbH
  • Merck & Co., Inc.
  • Novartis International AG
  • Sanofi
  • Stallergenes Greer
  • Torii Pharmaceutical Co. Ltd.

Table Information